
Check the programme regularly for updates
Sunday 25 June
12.00-14.00
Registration
14.00-15.30
New regimens for TB and TPP to shape the future of TB treatment
Chair:
GL01 Francesca Conradie, WITS HEALTH, University of the Witwatersrand, South Africa
TB universal regimens; pros and cons for adults and pediatric population
GL02 Christian Leinhardt, WHO, French Institute for. Research on Sustainable Development (IRD), Montpellier
New regimens, new TB drugs: what to expect?
TPP for TB regimens
GL03 Saskia Den Boon, WHO
Target Product Profiles for Tests for TB Treatment Monitoring and Optimization
GL04 Samuel Schumacher, WHO, Geneva
Target Regimen Profiles (TRPs) for TB treatment - VIRTUAL
15.30-16.30
Industry symposia still TBC
16.30-17.00
Coffee Break
17:00-18.45
Opening session
Chair:
GL05 Opening Keynote Silvia Bino, Head of Infectious Diseases, Institute of Public Health
High priority and emerging pathogens in Albania
GL06 GM Award presented by S. Niemann
GL07 Gardner Middlebrook Award presented by BD
19:30
Welcome Reception
Monday 26 June
08:00-09:00
Registration
09:00-10:30
Host pathogens interaction in M tuberculosis
Chair:
GL08 Margarida Saraiva, i3S- Instituto de Investigação e Inovação em Saúde, University of Porto
Study of host pathogen interactions in TB by using an in clinico to in vitro to in vivo approach
GL09 Stephanie Boisson-Dupuis, Rockefeller University, NYC
Novel genetic etiologies in susceptibility to tuberculosis
10:30-11:00
Coffee Break
11:00-12:30
Resistance to new antitubercular drugs and clinical implications
Chair:
GL10 Claudio Köser, Cambridge University
The X(DR)-Files – I want to believe
12:30-13:30
Lunch
13:30-14:30
Poster Session 1
14:30-15:30
Future of next generation sequencing
Chair:
GL11 Conor Meehan, Nottingham Trent University
Improved DNA extraction and direct tNGS/WGS on clinical specimens
15:30-16:00
Coffee Break
16:00-17:00
Animal models to study mycobacterial infections
Chair:
GL12 Pere-Joan Cardona Iglesias, Hospital Universitari Germans Trias i Pujol, Badalona
Mouse models to study TB pathogenesis
GL13 Nicola Lore, IRCCS San Raffaele Scientific Institute
Mouse models to study host-pathogens interaction in M.abscessuss lung infections
17:00-18:30
Round Table: Bordering EU countries: Situation, challenges and way out (Availability and affordability of NGS technologies to control DR TB, Viral Diseases and AMR)
Chair: Hasan Hafizi, University Hospital for Lung diseases, Tirana
Round table discussion
20:00
Traditional Dinner @ Palace of the Brigades
Tuesday 27 June
08:30-09:00
Registration
09:00-10:30
Host pathogens interaction in NTMs
Chair:
GL14 Lucas Boeck, University Hospital Basel
Phenogenomic analyses: linking mycobacterial behaviours to molecular mechanisms
GL15 Stephen Leon Icaza, ipbs, Toulouse
The organoid revolution to assess mycobacterial pulmonary infections
10:30-11:00
Coffee Break
11:00-13:00
Innovation in diagnostics
Chair:
GL16 Morten Ruhwald, FIND, Geneva
Future trends and innovation in diagnostics for TB
13:00-14:00
Lunch
14:00-15:00
Poster Session 2
15:00-16:00
Innovation in diagnostics (cont.)
Chair:
Selected orals
16:00-16:30
Coffee Break
16:30-17:30
General Assembly
18:00-02:00
Guided tour of the city, dinner and party at the hotel
Wednesday 28 June
09.00-09.30
Registration
09.30-11.00
Session Nontuberculous mycobacteria, epidemiology and more
Chair:
GL17 Victor Næstholt Dahl, Aarhus University Hospital
Global trends of pulmonary infections with nontuberculous mycobacteria
11.00-11.30
Coffee Break
11:30-12.45
Session Nontuberculous mycobacteria, epidemiology and more
Chair:
Selected orals
12:45-13.30
Poster Awards and Closing Ceremony
Chair: